(Q58004270)

English

Can C4d Immunostaining on Endomyocardial Biopsies Be Considered a Prognostic Biomarker in Heart Transplant Recipients?

scientific article published on 01 October 2010

In more languages
default for all languages
No label defined

No description defined

Statements

Can C4d immunostaining on endomyocardial biopsies be considered a prognostic biomarker in heart transplant recipients? (English)

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit